Cartiva, a developer of orthopedic implants, has completed enrolling patients in its MOTION trial. The prospective, multi-center trial, which has enrolled 233 patients across Canada and the UK, is designed to assess the company's ...
Tags: Cartiva, clinical trial, clinical technology
PHILADELPHIA, PA, July 30, 2012 /24-7PressRelease/ -- Social media is part of everyday life. At Silvers, Langsam & Weitzman, P.C., we maintain a blog, make status updates on Facebook and Tweet regularly. We understand that social media is a ...
Tags: social media, status update, online life, online communication
AMTAC Certification Services has granted CE mark for CellAegis Devices's autoRIC device. The CE mark allows CellAegis to sell autoRIC Device to 32 member countries and seven cooperating countries of the european economic area, under ...
Tags: AMTAC, CE Mark, medical device
CareFusion has completed the acquisition of a distributor of medical technologies, UK Medical. UK Medical distributes interventional and implantable single-use medical products for biopsy, cardiac, drainage, obstetrics and gynecology, ...
Medtronic has introduced the Endurant II AAA Stent Graft system in the US, following the US Food and Drug Administration's (FDA) approval. The Endurant II AAA Stent Graft system is designed for the treatment of abdominal aortic aneurysms ...
Tags: Medtronic, Endurant II AAA Stent Graft system, FDA, EVAR
Aspen Dental will inaugurate a new dental practice in Dothan, Alabama, US, on 20 December 2012. The new office will provide each patient with a customized treatment plan, following the initial exam and X-rays, as well as offer special ...
Tags: Dental, Dental Practice, Aspen Dental, treatment plan
ConvaTec, a developer of new medical technologies, has inaugurated a new office at the World Trade Center in Bangalore, India. The new facility, which will serve as headquarters for the company's Indian operations, will offer hospitals ...
Tags: medical technologies, medical, Convatec, healthcare, New Office
AirXpanders has obtained CE mark approval for its needle-free, patient-controlled tissue expander, designed for patients undergoing breast reconstruction after a mastectomy. The new technology, AeroForm, incorporates new capabilities ...
Tags: AirXpanders, AeroForm, mastectomy
Healthpoint Biotherapeutics, a developer of dermal repair and regeneration products, has launched a new size of OASIS Ultra Tri-Layer Matrix, designed for managing chronic wounds particularly in outpatient sites of care. The new 5 cm x 7 ...
Tags: Healthpoint, OASIS Ultra, ECM material, SIS
Regulators must force banks to overhaul complex IT infrastructures which risk causing further large-scale system outages, IT trade body Intellect has urged. The UK’s financial IT infrastructure is no longer fit for purpose and risks ...
Tags: IT infrastructure, IT trade, financial IT infrastructure
Cook Medical has received the US Food and Drug Administration (FDA) approval for its new Evolution colonic controlled-release stent. The new stent design features Kink-resistant flexor technology-based delivery system for pushability ...
Tags: Cook Medical, FDA, medical technology
Spacelabs Healthcare, a division of OSI Systems, has received the US Food and Drug Administration's 510(k) approval for its Blease900 ventilator. The Blease900 ventilator, which is an integral component of its BleaseFocus anesthesia ...
Tags: FDA, OSI Systems, Blease900 ventilator
Maquet Cardiovascular has obtained CE mark approval for its new Intergard Synergy antimicrobial vascular graft. The Intergard Synergy graft releases broad spectrum antimicrobial agents including silver acetate and triclosan from its ...
Tags: Maquet Cardiovascular, approval, antimicrobial vascular graft
Cook Medical has presented three-year data from Zilver PTX trial, which demonstrated 70.7% primary patency in the superficial femoral artery at 36 months using Paclitaxel-eluting stents. The controlled, randomized trail compares to ...
Tags: Zilver PTX trial, clinical study, clinical application, Cook Medical
W. L. Gore & Associates has won CE mark for the GORE hybrid vascular graft designed to expand treatment options for optimal outflow by maximizing the number of access sites available. The GORE hybrid vascular graft is indicated for ...